Physician profile
Eva Hernandez
NPI 1487833372
$5,055.46
in general payments reported to CMS, 2019-2025
24 companies · $577 in 2025
The $577 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $160 · 2022: $164 · 2023: $1,428 · 2024: $2,727 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,632 · Education: $94.99 · Travel and Lodging: $3.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,632.38 |
| Education | $94.99 |
| Travel and Lodging | $3.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $786.53 | 2021-2025 | |
| Dermavant Sciences, INC. | $581.40 | 2023-2024 | Vtama |
| Incyte Corporation | $551.13 | 2023-2025 | Opzelura |
| Genzyme Corporation | $467.19 | 2022-2025 | |
| Lilly USA, LLC | $345.40 | 2023-2024 | Olumiant |
| Pfizer INC. | $342.60 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $319.56 | 2023-2024 | Dupixent, Libtayo |
| Mayne Pharma Commercial LLC | $200.44 | 2023-2025 | |
| Galderma Laboratories, L.P. | $193.87 | 2023-2025 | Aklief, Epsolay, Oracea |
| Amgen INC. | $145.01 | 2021-2025 | Otezla |
| Ucb, INC. | $142.38 | 2024-2025 | Bimzelx |
| Verrica Pharmaceuticals INC. | $138.11 | 2024 | Ycanth |
| Merz North America, INC. | $135.42 | 2023 | |
| Janssen Biotech, INC. | $133.25 | 2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $121.63 | 2021-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $112.74 | 2024 | Adbry |
| Sun Pharmaceutical Industries INC. | $111.90 | 2021-2024 | |
| Strata Skin Sciences, INC. | $76.22 | 2023-2024 | Xtrac |
| E.R. Squibb & Sons, L.L.C. | $59.63 | 2024 | Sotyktu |
| Journey Medical Corporation | $23.30 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.55 | 2025 | Jublia, Siliq, Cabtreo |
| Vyne Pharmaceuticals INC. | $18.20 | 2021 | |
| Almirall LLC | $16.45 | 2025 | Klisyri |
| Organon LLC | $11.55 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.